Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene
Stable production of recombinant SARS-CoV-2 receptor-binding domain in mammalian cells with co-expression of a fluorescent reporter and its validation as antigenic target for COVID-19 serology testing.
Arias-Arias JL, Molina-Castro SE, Monturiol-Gross L, Lomonte B, Corrales-Aguilar E
Biotechnol Rep (Amst). 2023 Mar;37:e00780. doi: 10.1016/j.btre.2022.e00780. Epub 2022 Dec 31.
PubMed Article

Plasmids from Article

ID Plasmid Purpose
161793pSBbi-RP-CoV2/RBD-puroTransposon-based SARS-CoV-2 RBD stable expression vector for protein production
161794pSBbi-RP-CoV2/stSpike-puroTransposon-based SARS-CoV-2 secretable trimeric Spike stable expression vector for protein production

Antibodies from Article